Last updated on February 2018

Non-interventional European Study of Trabectedin + PLD in the Treatment of Relapsed Ovarian Cancer (ROC) Patients


Brief description of study

Non-interventional, multicenter, prospective, European study to describe the effectiveness of trabectedin + PLD in the treatment of relapsed ovarian cancer (ROC) patients according to SmPC regardless of previous use of an antiangiogenic drug

Clinical Study Identifier: NCT02825420

Contact Investigators or Research Sites near you

Start Over

Antoine, MD

Institut d'Oncologie Hauts-de-Seine Nord
Neuilly sur Seine, France
  Connect »